Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 127, Issue 19
May 12 2016
Blood Cover Image for Volume 127, Issue 19

Table of Contents

BLOOD FLASHBACK

Desai RG, Fulton GP. Evidence for a vessel wall defect in immuno-thrombocytopenic hamsters. Blood. 1960;15(5):675-680.
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
High-Jaking the blood: resistance is fetal
Samir Taoudi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
INSIDE BLOOD COMMENTARY
Context matters in MLL-AF9–driven leukemias
Christopher Y. Park
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
INSIDE BLOOD COMMENTARY
Matriptase-2 links erythropoietin to iron
Thomas Benedict Bartnikas
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
INSIDE BLOOD COMMENTARY
Dissecting stroke for anti-VWF therapeutics
Jing-fei Dong
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
INSIDE BLOOD COMMENTARY
Establishing the UCB graft potentiality
John E. Wagner
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

BLOOD SPOTLIGHT

Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis
Clinical Trials & Observations
Brendan M. Weiss,Sandy W. Wong,Raymond L. Comenzo
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

REVIEW ARTICLE

Emerging roles for hemostatic dysfunction in malaria pathogenesis
Jamie M. O’Sullivan,Roger J. S. Preston,Niamh O’Regan,James S. O’Donnell
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CLINICAL TRIALS AND OBSERVATIONS

Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study
Clinical Trials & Observations
Andreas Tiede,Christoph J. Hofbauer,Sonja Werwitzke,Paul Knöbl,Saskia Gottstein,Rüdiger E. Scharf,Jürgen Heinz,Jürgen Groß,Katharina Holstein,Christiane Dobbelstein,Fritz Scheiflinger,Armin Koch,Birgit M. Reipert
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation
Maria I. Mascarenhas,Wendi A. Bacon,Chrysa Kapeni,Simon R. Fitch,Gillian Kimber,S. W. Priscilla Cheng,Juan Li,Anthony R. Green,Katrin Ottersbach
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

LYMPHOID NEOPLASIA

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
Ashima Shukla,Karan Rai,Vipul Shukla,Nagendra K. Chaturvedi,R. Gregory Bociek,Samuel J. Pirruccello,Hamid Band,Runqing Lu,Shantaram S. Joshi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

MYELOID NEOPLASIA

Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin
Brief Report
Na Man,Xiao-Jian Sun,Yurong Tan,Marta García-Cao,Fan Liu,Guoyan Cheng,Megan Hatlen,Haiming Xu,Ronit Shah,Nolan Chastain,Na Liu,Gang Huang,Yuan Zhou,Mengyao Sheng,Junhong Song,Feng-Chun Yang,Robert Benezra,Stephen D. Nimer,Lan Wang
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
Antonella Nai,Aude Rubio,Alessandro Campanella,Ophélie Gourbeyre,Irene Artuso,Jessica Bordini,Aurélie Gineste,Chloé Latour,Céline Besson-Fournier,Herbert Y. Lin,Hélène Coppin,Marie-Paule Roth,Clara Camaschella,Laura Silvestri,Delphine Meynard
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

THROMBOSIS AND HEMOSTASIS

ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice
Frederik Denorme,Friederike Langhauser,Linda Desender,Aline Vandenbulcke,Hanspeter Rottensteiner,Barbara Plaimauer,Olivier François,Tommy Andersson,Hans Deckmyn,Friedrich Scheiflinger,Christoph Kleinschnitz,Karen Vanhoorelbeke,Simon F. De Meyer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

TRANSPLANTATION

Development and validation of a rapid, aldehyde dehydrogenase bright–based cord blood potency assay
Kevin Shoulars,Pamela Noldner,Jesse D. Troy,Lynn Cheatham,Amanda Parrish,Kristin Page,Tracy Gentry,Andrew E. Balber,Joanne Kurtzberg
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

LETTERS TO BLOOD

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Clinical Trials & Observations
Nikoletta Lendvai,Andrew J. Yee,Ioanna Tsakos,Aeri Alexander,Sean M. Devlin,Hani Hassoun,Neha Korde,Alexander M. Lesokhin,Heather Landau,Sham Mailankody,Guenther Koehne,David J. Chung,Ola Landgren,Noopur S. Raje,Sergio Giralt
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
Clinical Trials & Observations
Anne Wanquet,Rudy Birsen,Richard Lemal,Mathilde Hunault,Véronique Leblond,Thérèse Aurran-Schleinitz
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

BLOOD WORK

Plasma cell leukemia mimicking acute myeloid leukemia
Erika M. Moore,Christine G. Roth
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
All Issues

Advertisement intended for health care professionals

STK10 regulates platelet function in arterial thrombosis and thromboinflammation
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials
Feasibility and Safety of Anti-PD1 First-Line Treatment of Classic Hodgkin Lymphoma: Do We See the Full Picture?
ReXPOsing a weakness in TP53-mutant MDS and AML
Making sense of factor VIII’s breakdown

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals